Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<Group xmlns="http://hl7.org/fhir">
<id value="33398"/>
<meta>
<versionId value="10"/>
<lastUpdated value="2023-12-05T13:11:45.375Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/study-eligibility-criteria"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Group</b><a name="33398"> </a><a name="hc33398"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceGroup "33398" Version "10" Updated "2023-12-05 13:11:45+0000" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-study-eligibility-criteria.html">StudyEligibilityCriteria</a></p></div><p><b>Artifact related artifact</b>: </p><p><b>Artifact Title</b>: StudyEligibilityCriteria: Type 2 diabetes and elevated BMI in 2016 meta-analysis</p><p><b>Artifact URL</b>: <a href="https://fevir.net/resources/Group/33398">https://fevir.net/resources/Group/33398</a></p><p><b>Artifact Date</b>: 2022-05-26 13:50:22+0000</p><p><b>Artifact Publisher</b>: Computable Publishing LLC</p><p><b>Artifact Copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>Artifact use context</b>: <span title="{https://fevir.net/resources/CodeSystem/179423 evidence-communication}">Evidence Communication</span>: <span title="Codes: {https://fevir.net/resources/CodeSystem/179423 StudyEligibilityCriteria}">StudyEligibilityCriteria</span></p><p><b>Artifact Contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>Artifact Author</b>: Brian S. Alper: </p><p><b>CombinationMethod</b>: all-of</p><blockquote><p><b>modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]</b></p></blockquote><p><b>identifier</b>: FEvIR Object Identifier/33398</p><p><b>type</b>: person</p><p><b>membership</b>: definitional</p><p><b>name</b>: Type_2_diabetes_and_elevated_BMI_in_2016_meta_analysis</p><p><b>description</b>: A conceptual group with 2 characteristics for study participant eligibility criteria that were used for a meta-analysis.</p><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: Type 2 diabetes</p><p><b>code</b>: Disease (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#64572001)</span></p><p><b>value</b>: Diabetes mellitus type 2 (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#44054006)</span></p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: BMI > 25 kg/m2</p><p><b>code</b>: Body mass index (BMI) [Ratio] <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#39156-5)</span></p><p><b>value</b>: >25 kg/m2<span style="background: LightGoldenRodYellow"> (Details: UCUM code kg/m2 = 'kg/m2')</span></p><p><b>exclude</b>: false</p></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact">
<valueRelatedArtifact>
<type value="cite-as"/>
<citation
value="StudyEligibilityCriteria: Type 2 diabetes and elevated BMI in 2016 meta-analysis [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 33398. Revised 2022-05-26. Available at: https://fevir.net/resources/Group/33398. Computable resource at: https://fevir.net/resources/Group/33398."/>
</valueRelatedArtifact>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-title">
<valueString
value="StudyEligibilityCriteria: Type 2 diabetes and elevated BMI in 2016 meta-analysis"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-url">
<valueUri value="https://fevir.net/resources/Group/33398"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-date">
<valueDateTime value="2022-05-26T13:50:22.651Z"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-publisher">
<valueString value="Computable Publishing LLC"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-copyright">
<valueMarkdown
value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-useContext">
<valueUsageContext>
<code>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="evidence-communication"/>
<display value="Evidence Communication"/>
</code>
<valueCodeableConcept>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="StudyEligibilityCriteria"/>
<display value="StudyEligibilityCriteria"/>
</coding>
</valueCodeableConcept>
</valueUsageContext>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-contact">
<valueContactDetail>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</valueContactDetail>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
<valueContactDetail>
<name value="Brian S. Alper"/>
</valueContactDetail>
</extension>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/combination-method">
<valueCode value="all-of"/>
</extension>
<modifierExtension
url="http://hl7.org/fhir/StructureDefinition/artifact-status">
<valueCode value="active"/>
</modifierExtension>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="33398"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<type value="person"/>
<membership value="definitional"/>
<name value="Type_2_diabetes_and_elevated_BMI_in_2016_meta_analysis"/>
<description
value="A conceptual group with 2 characteristics for study participant eligibility criteria that were used for a meta-analysis."/>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description">
<valueMarkdown value="Type 2 diabetes"/>
</extension>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="64572001"/>
<display value="Disease (disorder)"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="44054006"/>
<display value="Diabetes mellitus type 2 (disorder)"/>
</coding>
</valueCodeableConcept>
<exclude value="false"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description">
<valueMarkdown value="BMI > 25 kg/m2"/>
</extension>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="39156-5"/>
<display value="Body mass index (BMI) [Ratio]"/>
</coding>
</code>
<valueQuantity>
<value value="25"/>
<comparator value=">"/>
<unit value="kg/m2"/>
<system value="http://unitsofmeasure.org"/>
<code value="kg/m2"/>
</valueQuantity>
<exclude value="false"/>
</characteristic>
</Group>
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2024-05-16
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change